drugset / Trial / NCT00216580
A Pilot Study of the Use of Risperidone Long Acting Injectable in the Treatment of Patients With Recent Onset Psychosis
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to assess the effectiveness and safety of long-acting injectable risperidone in the treatment of patients in the early stage of psychosis
Timeline
- Start
- 2004-02
- Primary completion
- —
- Completion
- 2006-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Risperidone | Other / unclassified | 25 mg | — |
| Subject | Risperidone | Other / unclassified | 37.5 mg | — |
| Subject | Risperidone | Other / unclassified | 50 mg | — |